Study identifier:5077IL/0120
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An Open Label, Safety, Tolerability, and Steady State Pharmacokinetic Drug Interaction Study of the Effect of Co-administered Quetia[pine Fumarate (Seroquel ) and Divalproex Sodium (Depakote Sprinkle) in Subjects with Schizophrenic/Schizoaffective Disorders or in Subjects with Bipolar Disorder
mania
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|